|
Date of publication/authors
|
Number of patients
|
Anti-coagulation
|
Cortico-steroids
|
Immuno-suppressive therapy
|
Surgery
|
Endovascular treatment
|
Outcome
|
Follow up (months)
|
|---|
|
1980/ [11]
|
1
|
0
|
0
|
0
|
0
|
0
|
death
|
4
|
|
1996/ [20]
|
1
|
0
|
0
|
0
|
1(thrombectomy)
|
0
|
death
|
During surgery
|
|
2000/ [23]
|
1
|
0
|
0
|
0
|
0
|
0
|
favourable
|
180
|
|
1983/ [13]
|
1
|
T
|
0
|
0
|
0
|
0
|
favourable
|
72
|
|
No treatment
|
4
|
0 (T, n =1)
|
0
|
0
|
1 thrombectomy
|
0
|
Death n = 2 (50%)
| |
|
1985/ [14]
|
1
|
0
|
1
|
1
|
0
|
0
|
favourable
|
24
|
|
2002/ [24]
|
1
|
0
|
1
|
1
|
0
|
0
|
death
|
3
|
|
2007/ [28]
|
1
|
0
|
1
|
0
|
0
|
thrombolysis (failure)
|
death
|
ND
|
|
2007/ [29]
|
3
|
0
|
3
|
3
|
0
|
0
|
death (n = 2) favourable (n = 1)
|
7;7;6
|
|
No ATCG
|
6
|
0
|
6
|
5
|
0
|
0
|
Death n = 4 (67%)
| |
|
1983/ [12]
|
1
|
1
|
0
|
0
|
1(shunt)
|
0
|
death
|
1
|
|
1986/ [15]
|
1
|
1
|
0
|
0
|
0
|
1 (stent)
|
favourable
|
36
|
|
1991/ [18]
|
1
|
1
|
0
|
0
|
0
|
0
|
death
|
1.25
|
|
1990/ [17]
|
1
|
1
|
0
|
0
|
0
|
0
|
favourable
|
24
|
|
2008/ [30]
|
1
|
1
|
0
|
0
|
0
|
0
|
death
|
ND
|
|
ATCG alone
|
5
|
5
|
0
|
0
|
1
|
1
|
Death n = 3 (60%)
| |
|
1990/ [17]
|
3
|
3 (T, n = 1)
|
2
|
1
|
2 (shunt)
|
0
|
death (n = 1)
|
30;4;4
|
|
2002/ [25]
|
1
|
1
|
1
|
0
|
1
|
0
|
relapse (n = 1)
|
60
|
|
2004/ [26]
|
1
|
1
|
1
|
1
|
0
|
dilatation and stent
|
favourable
|
0.25
|
|
2007/ [27]
|
4
|
4
|
4
|
4
|
0
|
0
|
death (n = 1)
|
1;96;48;36
|
|
2008/ [30]
|
6
|
6
|
6
|
2
|
0
|
0
|
favourable (n = 6)
|
43
|
|
2011/ [31]
|
1
|
1
|
1
|
1
|
0
|
0
|
favourable
|
1
|
|
2011/ [32]
|
1
|
1
|
1
|
1
|
0
|
0
|
alive
|
1.5
|
|
ATCG and IS
|
17
|
17
|
16
|
10
|
3
|
1
|
Death n = 2 (12%)
| |
|
TOTAL
|
32
|
ATC 22 (69%)
|
22 (69%)
|
15 (47%)
|
5 (16%)
|
3 (9%)
|
12 (38%)
|
29.7 months
|
| | |
Thrombolysis 2 (6%)
| | | | | | |
- Abbreviations: ATC Anticoagulation, IS Immunosuppressants, ND No determined, PT Prothrombin time, T Thrombolysis.
